Prospective evaluation of combined oncological and functional outcomes after laparoscopic radical prostatectomy: Trifecta rate of achieving continence, potency and cancer control at 2 years

BJU International

Volumn 107, Issue 2, 2011, Pages 274-279

  Ploussard, Guillaume ^a   De La Taille, Alexandre ^a   Xylinas, Evanguelos ^a   Allory, Yves ^a   Vordos, Dimitri ^a   Hoznek, Andras ^a   Abbou, Claude Clément ^a   Salomon, Laurent ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

continence; laparoscopy; potency; prostate neoplasm; prostatectomy; recurrence free survival; trifecta

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BIOCHEMISTRY; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CONTINENCE; DIAPER; DISEASE FREE SURVIVAL; ERECTILE DYSFUNCTION; GLEASON SCORE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PHYSICAL ACTIVITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; QUESTIONNAIRE; SEXUAL INTERCOURSE; TREATMENT OUTCOME; URINE INCONTINENCE;

ADULT; AGED; EPIDEMIOLOGIC METHODS; ERECTILE DYSFUNCTION; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RECOVERY OF FUNCTION; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 78651076135     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09462.x     Document Type: Article

References (25)

1. Noldus J, Graefen M, Haese A, et al. Stage migration in clinically localized prostate cancer. Eur Urol 2000; 38: 74-8
2. Brandeis J, Pashos CL, Henning JM, Litwin MS,. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer 2000; 89: 1792-9
3. Dubbelman YD, Dohle GR, Schroder FH,. Sexual function before and after radical retropubic prostatectomy: a systematic review of prognostic indicators for a successful outcome. Eur Urol 2006; 50: 711-8; discussion 718-20
4. Rabbani F, Stapleton AM, Kattan MW, et al. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000; 164: 1929-34
5. Walsh PC, Marschke P, Ricker D, Burnett AL,. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000; 55: 58-61 (Pubitemid 30050758)
6. Hoznek A, Salomon L, Olsson LE, et al. Laparoscopic radical prostatectomy. The Creteil experience. Eur Urol 2001; 40: 38-45 (Pubitemid 32786120)
7. Rassweiler J, Hruza M, Teber D, Su LM,. Laparoscopic and robotic assisted radical prostatectomy-critical analysis of the results. Eur Urol 2006; 49: 612-24 (Pubitemid 43374721)
8. Rassweiler J, Schulze M, Teber D, et al. Laparoscopic radical prostatectomy: functional and oncological outcomes. Curr Opin Urol 2004; 14: 75-82
9. Stolzenburg JU, Rabenalt R, Do M, et al. Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures. J Urol 2005; 174: 1271-5; discussion 1275
10. Ficarra V, Novara G, Artibani W, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009; 55: 1037-63
11. Touijer K, Secin FP, Cronin AM, et al. Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience. Eur Urol 2009; 55: 1014-9
12. Salomon L, Saint F, Anastasiadis AG, et al. Combined reporting of cancer control and functional results of radical prostatectomy. Eur Urol 2003; 44: 656-60 (Pubitemid 37542922)
13. Bianco FJ Jr, Scardino PT, Eastham JA., Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ('trifecta'). Urology 2005; 66: 83-94
14. Eastham JA, Scardino PT, Kattan MW,. Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. J Urol 2008; 179: 2207-10; discussion 2210-2201
15. Pierorazio PM, Spencer BA, McCann TR, et al. Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy. Urology 2007; 70: 717-22
16. Shikanov SA, Zorn KC, Zagaja GP, Shalhav AL,. Trifecta outcomes after robotic-assisted laparoscopic prostatectomy. Urology 2009; 74: 619-23
17. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129-35
18. Litwin MS, Pasta DJ, Yu J, et al. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 2000; 164: 1973-7
19. Catalona WJ, Carvalhal GF, Mager DE, Smith DS,. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433-8
20. Litwin MS, Pasta DJ, Stoddard ML, et al. Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993. J Urol 1998; 160: 445-8
21. Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002-12
22. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002; 346: 1138-44
23. Vickers AJ, Bianco FJ, Serio AM, et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 2007; 99: 1171-7
24. Fowler FJ Jr, Barry MJ, Lu-Yao G, et al. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 1995; 45: 1007-13; discussion 1013-1005
25. Amling CL, Blute ML, Bergstralh EJ, et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol 2000; 164: 101-5